Recent studies have shown that popular diabetes drugs like Januvia and Janumet may be associated with pancreatic cancer and thyroid cancer.
Although the maker of the drugs, Merck, hasn’t added any warnings about the link to cancer, patients may be reacting to the reports as sales of Januvia have dropped.
Januvia is Merck’s best selling drug at over $4 billion last year. It works by inhibiting an enzyme to promote insulin production. However, that enzyme may also be a crucial natural defense against cancer. Janumet combines Januvia with traditional diabetes med Metformin to work in a similar way.
This week, Merck reported that sales of Januvia dropped 4% from last year. Although it blamed the drop on a reduced supply, many analysts believe fewer patients want to use the drug.
In 2011, researchers from UCLA reported findings from a study which showed animals given Januvia were 172% more likely to develop pancreatic cancer and 48% more likely to develop thyroid cancer.
The FDA ordered Merck to conduct new testing for Janumet and Januvia in 2011. However, records show that by February of 2012, they were still delaying the tests.
This year, both the Journal for the American Medical Association and Institute for Safe Medication Practices have warned that drugs like Januvia and Janumet may substantially increase the risk of pancreatitis, a major risk factor for pancreatic cancer.
Patients affected by Januvia pancreatic cancer or Janumet cancer have already come forward to file a Januvia lawsuit. Recently, lawyers asked that the growing cases be consolidated to a special federal multi-district court in California (MDL 2452).
If you or a loved one were diagnosed with thyroid or pancreatic cancer after taking Januvia or Janumet, it is important to speak with a lawyer as soon as possible. You may be entitled to compensation, however, time is limited.
Federal drug injury cases can be very specialized. Therefore, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer.